FIG. 4.
Mean plasma LB80331 concentration profile in CHB patients following the administration of a oral single dose of LB80380 of 30, 60, 120, or 240 mg daily (day 1) and at steady state (weeks 2 to 4). Data are means ± standard deviations.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.